[
  {
    "ts": null,
    "headline": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2025 Update",
    "summary": "Read here for an in-depth analysis and insights on Fundsmith's $23.02B portfolio shift: new stakes, exits, and top positions like Meta and Microsoft.",
    "url": "https://finnhub.io/api/news?id=f087a6c6a6d6cfcabdcfb810056bf11ae98ef58c69a306cd2f63c8e75ef7e9b4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756335851,
      "headline": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2025 Update",
      "id": 136555000,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/538053368/image_538053368.jpg?io=getty-c-w1536",
      "related": "SYK",
      "source": "SeekingAlpha",
      "summary": "Read here for an in-depth analysis and insights on Fundsmith's $23.02B portfolio shift: new stakes, exits, and top positions like Meta and Microsoft.",
      "url": "https://finnhub.io/api/news?id=f087a6c6a6d6cfcabdcfb810056bf11ae98ef58c69a306cd2f63c8e75ef7e9b4"
    }
  },
  {
    "ts": null,
    "headline": "How Investors May Respond To Stryker (SYK) Raising 2025 Guidance on Robotics and Innovation Momentum",
    "summary": "Stryker Corporation recently announced strong second-quarter 2025 results, highlighting robust momentum in its orthopaedics, MedSurg, and Neurotechnology businesses, driven by increased robotics adoption and ongoing innovation. Management’s decision to raise full-year sales and adjusted earnings guidance reflects growing confidence in the company’s product pipeline and resilience against industry headwinds and competitive pressures. Next, we'll explore how Stryker's upgraded guidance and...",
    "url": "https://finnhub.io/api/news?id=49a0fa2213c20b83101c83faf033fbef82719c3640387a10c0dccccb2d787f3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756289315,
      "headline": "How Investors May Respond To Stryker (SYK) Raising 2025 Guidance on Robotics and Innovation Momentum",
      "id": 136536634,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SYK",
      "source": "Yahoo",
      "summary": "Stryker Corporation recently announced strong second-quarter 2025 results, highlighting robust momentum in its orthopaedics, MedSurg, and Neurotechnology businesses, driven by increased robotics adoption and ongoing innovation. Management’s decision to raise full-year sales and adjusted earnings guidance reflects growing confidence in the company’s product pipeline and resilience against industry headwinds and competitive pressures. Next, we'll explore how Stryker's upgraded guidance and...",
      "url": "https://finnhub.io/api/news?id=49a0fa2213c20b83101c83faf033fbef82719c3640387a10c0dccccb2d787f3e"
    }
  }
]